GlassScriptPhysician profile
Elizabeth Howcroft
NPI 1093277493
$1,013.27
in general payments reported to CMS, 2019-2025
11 companies · $99.38 in 2025
The $99.38 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $104 · 2021: $11.49 · 2022: $269 · 2023: $178 · 2024: $351 · 2025: $99.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $628.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $627.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $339.56 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Pulmonx Corporation | $191.95 | 2024-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Medtronic, INC. | $126.22 | 2022 | |
| Abbvie INC. | $103.89 | 2022-2023 | |
| Allergan, INC. | $93.08 | 2020 | |
| Merck Sharp & Dohme LLC | $66.19 | 2021-2022 | |
| Amgen INC. | $25.80 | 2025 | Tavneos |
| Insmed, INC. | $20.50 | 2025 | Arikayce |
| Astrazeneca Pharmaceuticals LP | $20.29 | 2025 | Fasenra |
| Regeneron Healthcare Solutions, INC. | $14.44 | 2025 | Dupixent |
| Biomerieux INC | $11.35 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Howcroft listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.